| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $4,616,000 | 3 | 100 |
Sells | $0 | 0 | 0 |
| Cherington Charles | 10 percent owner | 3 | $4.62M | 0 | $0 | $4.62M |
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Over the last 12 months, insiders at Ernexa Therapeutics Inc. have bought $4.62M and sold $0 worth of Ernexa Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Ernexa Therapeutics Inc. have bought $7,999.87B and sold $7.5M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Cherington Charles (10 percent owner) — $4.62M.
The last purchase of 4,000,000 shares for transaction amount of $2M was made by Cherington Charles (10 percent owner) on 2026‑02‑10.
| 2026-02-10 | Cherington Charles | 10 percent owner | 4M 83.4958% | $0.50 | $2M | -0.95% | ||
| 2025-06-09 | Cherington Charles | 10 percent owner | 21.24M 18.8502% | $0.10 | $2.22M | -53.87% | ||
| 2025-04-02 | Cherington Charles | 10 percent owner | 3.77M 3.9501% | $0.10 | $394,174 | -50.87% | ||
| 2024-10-29 | Cherington Charles | 10 percent owner | 13.25M – | $2.41M | $31,999.46B | -81.70% | ||
| 2024-09-24 | Cherington Charles | 10 percent owner | 13.25M 20.0594% | $0.33 | $4.38M | -78.55% | ||
| 2022-12-02 | Cherington Charles | director | 261,756 3.9322% | $3.28 | $858,560 | -16.36% | ||
| 2022-12-02 | HALPERN JOHN D | director | 335,920 5.0463% | $3.28 | $1.1M | -16.36% | ||
| 2022-12-02 | Singer Nicholas Jason | director | 283,286 4.2556% | $3.28 | $929,178 | -16.36% | ||
| 2021-07-14 | DENNY GEORGE P III | 10 percent owner | 1 <0.0001% | $11.99 | $12 | -69.43% | ||
| 2021-07-09 | DENNY GEORGE P III | 10 percent owner | 1 <0.0001% | $14.11 | $14 | -70.12% | ||
| 2021-07-08 | DENNY GEORGE P III | 10 percent owner | 1 <0.0001% | $14.35 | $14 | -71.92% | ||
| 2021-07-06 | Sale | DENNY GEORGE P III | 10 percent owner | 75,000 5.5174% | $16.06 | $1.2M | -73.58% | |
| 2021-06-17 | Sale | Cherington Charles | 200,000 14.426% | $15.75 | $3.15M | -67.47% | ||
| 2021-06-16 | Sale | Cherington Charles | 200,000 14.412% | $15.73 | $3.15M | -67.72% | ||
| 2020-08-13 | Sale | ELLIN ROBERT S | 10 percent owner | 327,650 8.3217% | $5.55 | $1.82M | -26.35% | |
| 2020-06-17 | Sale | ELLIN ROBERT S | 10 percent owner | 12,400 0.3413% | $6.01 | $74,524 | -5.23% | |
| 2020-06-16 | Sale | ELLIN ROBERT S | 10 percent owner | 100 0.0018% | $3.86 | $386 | -49.67% | |
| 2020-06-03 | Sale | Berg Jeffrey Alan | 10 percent owner | 21,932 0.1102% | $1.10 | $24,059 | +83.75% | |
| 2020-06-02 | Sale | Berg Jeffrey Alan | 10 percent owner | 30,730 0.1393% | $0.99 | $30,423 | +131.05% | |
| 2020-06-01 | Sale | Berg Jeffrey Alan | 10 percent owner | 30,000 0.1455% | $1.06 | $31,770 | +104.67% |
| Cherington Charles | 10 percent owner | 6779440 86.3283% | $1.93M | 5 | 2 | <0.0001% |
| BROADWOOD PARTNERS, L.P. | 29971561 381.653% | $8.54M | 15 | 0 | ||
| BRADSHER NEAL C | 9322262 118.7082% | $2.66M | 3 | 0 | ||
| Trinad Capital Master Fund Ltd. | 10 percent owner | 8900093 113.3324% | $2.54M | 41 | 0 | |
| Fidelity National Financial, Inc. | 10 percent owner | 5921811 75.4074% | $1.69M | 0 | 15 | |
| WEST MICHAEL D | Co-Chief Executive Officer | 882864 11.2422% | $251,616.24 | 3 | 1 | |
| HALPERN JOHN D | director | 450961 5.7425% | $128,523.89 | 1 | 0 | <0.0001% |
| BUSH MICHAEL J | CEO | 300478 3.8262% | $85,636.23 | 14 | 0 | |
| Berg Jeffrey Alan | 10 percent owner | 276100 3.5158% | $78,688.50 | 26 | 9 | |
| Khuchua Vladimir | EVP and Chief Product Officer | 272700 3.4725% | $77,719.50 | 4 | 0 | |
| Singer Nicholas Jason | director | 266214 3.3899% | $75,870.99 | 1 | 0 | <0.0001% |
| AWM Investment Company, Inc. | 10 percent owner | 251562 3.2034% | $71,695.17 | 0 | 28 | |
| Yanover Paul | director | 205000 2.6104% | $58,425.00 | 2 | 0 | |
| LICHTINGER PEDRO | director | 126250 1.6076% | $35,981.25 | 2 | 0 | |
| Farricielli Joseph J. Jr. | director | 110000 1.4007% | $31,350.00 | 15 | 0 | |
| Keymer Kenneth L | director | 98100 1.2492% | $27,958.50 | 3 | 0 | |
| FARRELL STEPHEN C | director | 97450 1.2409% | $27,773.25 | 6 | 0 | |
| Wolff Allen | CFO and EVP | 95500 1.2161% | $27,217.50 | 3 | 0 | |
| MOHANTY ADITYA P. | Co-Chief Executive Officer | 89696 1.1422% | $25,563.36 | 1 | 0 | |
| Santana Dario Loreto | President and CEO | 75000 0.955% | $21,375.00 | 1 | 0 | |
| Russell Angus C. | director | 67500 0.8595% | $19,237.50 | 1 | 0 | |
| Simtob Richard Isaac | director | 52088 0.6633% | $14,845.08 | 3 | 0 | |
| CLASEN ROBERT B | director | 50000 0.6367% | $14,250.00 | 1 | 0 | |
| SCHLACHET DAVID | director | 32050 0.4081% | $9,134.25 | 1 | 0 | |
| Bourbiel Jennifer | Vice President, Marketing | 15000 0.191% | $4,275.00 | 1 | 0 | |
| Mitgang Steve | director | 15000 0.191% | $4,275.00 | 2 | 0 | |
| ARLEN GARY H | director | 10450 0.1331% | $2,978.25 | 1 | 0 | |
| COHEN ABRAHAM E | director | 10000 0.1273% | $2,850.00 | 1 | 0 | |
| Lewis Mary Beth | director | 10000 0.1273% | $2,850.00 | 1 | 0 | |
| Glassman Nicholas A | EVP of Product and Technology | 10000 0.1273% | $2,850.00 | 1 | 0 | |
| Uphoff Tony | director | 9600 0.1222% | $2,736.00 | 1 | 0 | |
| GARCIA PETER S | Chief Financial Officer | 7000 0.0891% | $1,995.00 | 2 | 0 | |
| Krishnan Ram | CEO | 5900 0.0751% | $1,681.50 | 4 | 0 | |
| Miller Dave Brian | SVP Marketing | 5600 0.0713% | $1,596.00 | 6 | 0 | |
| TEW WILLIAM P PHD | Chief Commercial Officer | 3265 0.0416% | $930.53 | 0 | 5 | |
| SKIBSTED RUSSELL | Chief Financial Officer | 2000 0.0255% | $570.00 | 1 | 0 | |
| George Christopher Allen | SVP and CHIEF INFORMATION OFF | 600 0.0076% | $171.00 | 1 | 0 | |
| BERGER FRANKLIN M | director | 500 0.0064% | $142.50 | 1 | 0 | |
| ELLIN ROBERT S | 10 percent owner | 421 0.0054% | $119.99 | 21 | 4 | |
| DENNY GEORGE P III | 10 percent owner | 3 0% | $0.86 | 3 | 1 | <0.0001% |
$1,848,072 | 66 | -14.67% | $1.89M | |
$53,490,060 | 55 | 19.35% | $3.28M | |
$1,138,733 | 28 | -4.94% | $3.34M | |
$337,688 | 19 | -33.30% | $2.36M | |
$8,079,884 | 14 | -43.20% | $1.33M | |
$82,890 | 11 | -16.74% | $1.82M | |
$389,864 | 11 | 12.52% | $2.51M | |
$105,917 | 11 | -28.06% | $2.42M | |
$18,269 | 10 | -21.15% | $2.61M | |
$126,023 | 10 | -66.17% | $1.65M | |
Eterna Therapeutics Inc. (ERNA) | $7,268,979 | 7 | -48.44% | $2.24M |
$245,000 | 7 | -62.00% | $2.14M | |
$70,828 | 6 | -57.96% | $1.67M | |
$726,438 | 4 | -72.85% | $1.3M | |
$149,778 | 4 | -45.16% | $3.24M | |
$19,863 | 1 | 144.27% | $991,933.00 | |
$9,963 | 1 | -14.25% | $2.27M | |
$37,000 | 1 | 79.42% | $3.75M | |
$1,049,630 | 1 | -74.91% | $851,946.00 |
| Increased Positions | 6 | +40% | 41,969 | +8.12% |
| Decreased Positions | 4 | -26.67% | 36,199 | -7% |
| New Positions | 3 | New | 14,029 | New |
| Sold Out Positions | 3 | Sold Out | 36,152 | Sold Out |
| Total Postitions | 17 | +13.33% | 522,698 | +1.12% |
| Corient Private Wealth Llc | $508.00 | 5.48% | 438,092 | +420,569 | +2,400.1% | 2025-09-30 |
| Susquehanna International Group, Llp | $36.00 | 0.39% | 30,854 | +30,854 | New | 2025-09-30 |
| Geode Capital Management, Llc | $24.00 | 0.26% | 20,453 | +378 | +1.88% | 2025-09-30 |
| Vanguard Group Inc | $13.00 | 0.14% | 11,147 | +11,147 | New | 2025-09-30 |
| Sippican Capital Advisors | $12.00 | 0.13% | 10,000 | 0 | 0% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $6.00 | 0.07% | 5,182 | +5,182 | New | 2025-09-30 |
| Blackrock, Inc. | $1.00 | 0.01% | 820 | 0 | 0% | 2025-09-30 |
| Assetmark, Inc | $0 | <0.01% | 133 | 0 | 0% | 2025-09-30 |
| Eversource Wealth Advisors, Llc | $0 | <0.01% | 116 | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $0 | <0.01% | 77 | -477 | -86.1% | 2025-09-30 |